Works by HARUKA WAKABAYASHI
Results: 6
Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 799, doi. 10.1159/000533325
- By:
- Publication type:
- Article
Evaluation of Cardiac Adverse Events with Ponatinib Using a Spontaneous Reporting Database.
- Published in:
- Oncology, 2023, v. 101, n. 6, p. 397, doi. 10.1159/000529768
- By:
- Publication type:
- Article
Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 360, doi. 10.21873/invivo.13836
- By:
- Publication type:
- Article
Evaluation of Lung Adverse Events Associated With Lenvatinib: A Post-marketing Surveillance Study.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 346, doi. 10.21873/invivo.13834
- By:
- Publication type:
- Article
Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 12, p. 3348, doi. 10.1111/bcp.16237
- By:
- Publication type:
- Article
Pharmacists' Behavioral Changes after Attending a Multi-Prefectural Palliative Care Education Program.
- Published in:
- Pharmacy, 2024, v. 12, n. 3, p. 87, doi. 10.3390/pharmacy12030087
- By:
- Publication type:
- Article